News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Lytix Biopharma as Update on Phase I Progress with Oncopore(TM) for Solid Tumors


5/20/2010 10:53:58 AM

OSLO--(BUSINESS WIRE)--The Norwegian pharmaceutical company Lytix Biopharma AS provided an update at the recent BIO conference in Chicago on Phase I clinical trials of OncoporeTM (LTX-315) for the treatment of cancer.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES